These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 23686413

  • 1. Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of its use in high risk patients.
    Cignetti A, Ruella M, Elia A, Tassi V, Redoglia V, Gottardi D, Tarella C.
    Am J Hematol; 2013 Aug; 88(8):720-1. PubMed ID: 23686413
    [No Abstract] [Full Text] [Related]

  • 2. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A, Ciceri F, Gluckman E, Labopin M, Rocha V, Eurocord and Acute Leukemia Working Party of the European Blood and Marrow Transplant Group.
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 4. Treatment of high-risk chronic GVHD.
    Pavletic S, Vogelsand GB.
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1436-7. PubMed ID: 19041069
    [No Abstract] [Full Text] [Related]

  • 5. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients.
    Muetherig A, Christopeit M, Müller LP, Grothe W, Weber T, Theurich S, Behre G.
    Bone Marrow Transplant; 2007 Mar; 39(5):315-6. PubMed ID: 17311086
    [No Abstract] [Full Text] [Related]

  • 6. Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution.
    Kim HJ, Min WS, Kim YJ, Kim DW, Lee JW, Kim CC.
    Bone Marrow Transplant; 2005 May; 35(10):959-64. PubMed ID: 15778730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission.
    Fagioli F, Zecca M, Locatelli F, Lanino E, Uderzo C, Di Bartolomeo P, Berger M, Favre C, Rondelli R, Pession A, Messina C, AIEOP-HSCT group.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):575-83. PubMed ID: 18799933
    [Abstract] [Full Text] [Related]

  • 9. Canadian multicenter pilot trial of haploidentical donor transplantation.
    Walker I, Shehata N, Cantin G, Couture F, Dhédin N, Barty R, Foley R, Sutherland RD, Sigouin C, Schultz KR, Mitchell D, Canadian Blood and Marrow Transplant Group.
    Blood Cells Mol Dis; 2004 Aug; 33(3):222-6. PubMed ID: 15528135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mesenteric inflammatory veno-occlusive disease (MIVOD) after allogeneic peripheral blood stem cell transplantation (PBSCT).
    Pérez-Corral AM, Serrano D, Menarguez-Palanca J, Carrión R, Barreiro I, Gómez-Pineda A, Buño I, Balsalobre P, Diez-Martín JL.
    Bone Marrow Transplant; 2008 Feb; 41(3):311-3. PubMed ID: 18026155
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia.
    Cho BS, Yoon JH, Shin SH, Yahng SA, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ.
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1552-63. PubMed ID: 22516055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.